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Regulation of macula densa Na:H exchange by angiotensin II.
Background: Angiotensin II (Ang II) is a positive modulator of
tubuloglomerular feedback (TGF). At the present time, the site(s)
at which Ang II interacts with the signal transmission process
remains unknown. In certain renal epithelia, Ang II is known to
stimulate apical Na:H exchange. Since macula densa cells possess
an apical Na:H exchanger and Ang II subtype I receptors (AT1-
receptors), we tested the possibility that Ang II might stimulate
exchanger activity in these cells.
Methods. Using the isolated perfused thick ascending limb with
attached glomerulus preparation dissected from rabbit kidney,
macula densa intracellular pH (pHi) was measured with fluores-
cence microscopy using BCECF.
Results. Control pHi, during perfusion with 25 mM NaCl and
150 mM NaCl in the bath, averaged 7.22 6 0.02 (N 5 24).
Increasing luminal [NaCl] to 150 mM elevated pHi by 0.54 6 0.04
(N 5 7, P , 0.01). Ang II (1029 M), added to the bath in the same
paired experiments, significantly elevated baseline pHi by 0.17 6
0.04, increased the magnitude of change in pHi (D 5 0.71 6 0.05)
and initial rate of alkalinization (by 69%) to increased luminal
[NaCl]. Ang II produced similar effects when added exclusively to
the luminal perfusate. In addition, low-dose Ang II (1029 M)
stimulated while high-dose Ang II (1026 M) inhibited Na-depen-
dent pH-recovery from an acid load. AT1 blockade prevented the
stimulatory but not the inhibitory effects of Ang II.
Conclusion. Through the AT1, Ang II may influence macula
densa Na transport and regulate cell alkalinization via the apical
Na:H exchanger. Thus, Ang II may modulate the TGF signal
transmission process, at least in part, through a direct effect on
macula densa cell function.
Tubuloglomerular feedback (TGF), a potent regulator of
intraglomerular hemodynamics, involves signal transduc-
tion from tubular lumen to glomerular vascular elements
[1–4]. Macula densa cells, which are located within the
cortical thick ascending limb (cTAL), function as the sensor
of TGF [3], detecting changes in luminal fluid [NaCl] and
signaling to the afferent arteriole, the effector of TGF.
Signal generation by macula densa cells occurs, at least in
part, through specific transport processes of macula densa
cells, and alterations or regulation of these pathways may
have the potential of modifying TGF responses [2–4].
The vasoconstrictor hormone angiotensin II (Ang II) is
generally considered to be a specific modulator of TGF.
Ang II has been shown to augment the magnitude of
feedback responses [5–9], and this function of Ang II is not
strictly due to its vasoconstrictor properties. At the present
time, the site(s) at which Ang II interacts with the signal
transmission process remain(s) unknown. Ang II receptors
are located on afferent arteriolar vascular smooth muscle
cells, and may be involved in modulation of feedback
signals [9]. Furthermore, recent work demonstrated the
existence of Ang II subtype I receptors (AT1-receptors) on
macula densa cells using immunohistochemistry [10]. This
finding opens the possibility that Ang II could have a
specific effect on macula densa cell function.
Besides its role as a vasoconstrictor, Ang II directly
effects tubular Na and HCO3 reabsorption; that is, it
normally stimulates apical Na:H exchange and/or basolat-
eral Na:HCO3 cotransport in proximal tubule [11–16], early
and late distal tubule [17–19], and cortical collecting duct
[20]. In terms of overall transepithelial transport of salt and
water, the effects of Ang II are biphasic with low concen-
trations (10212 to 1029 M) stimulating and high concentra-
tions (1027 to 1026 M) inhibiting reabsorption [13–15, 21].
Similar dose-response relationships have been obtained for
luminal and peritubular addition of Ang II [13–15]. This is
in agreement with the observation that Ang II receptors are
located at both the apical and basolateral membranes of
renal epithelial cells [10].
Besides the well known apical furosemide/bumetanide
sensitive Na:2Cl:K cotransporter [22–25], we have recently
shown that an apical Na:H exchanger exists in macula
densa cells [26]. In macula densa cells loaded with the
pH-sensitive fluorescent dye BCECF, increases in luminal
fluid [NaCl] from 25 to 150 mM resulted in intracellular
alkalinization. This apical transporter regulates intracellu-
lar pH (pHi) and may participate in Na transport by these
cells.
The purpose of these studies was to determine if Ang II
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regulates apical Na:H exchange in macula densa cells.
Since significant levels of Ang II have been detected in
renal tubular fluid [27, 28], the present study investigated
both luminal and basolateral actions of Ang II. Macula
densa pHi was measured using the fluorescent dye BCECF
with increased luminal [NaCl] in the presence of 1029 M
Ang II. We also examined whether the effects of Ang II
involved AT1-receptors, and characterized the effects of
low (1029 M) and high (1026 M) concentrations of Ang II on
macula densa Na:H exchanger activity.
METHODS
cTAL preparation
Individual cTALs with attached glomeruli were manually
dissected from sagittal slices of kidneys obtained from
female New Zealand white rabbits weighing approximately
0.5 kg. The dissection solution was a modified Ringer’s
solution composed of (in mM): 148 NaCl, 5 KCl, 1 MgSO4,
1.6 Na2HPO4, 0.4 NaH2PO4, 1.5 CaCl2 and 5 D-glucose.
Individual cTALs with glomeruli were transferred to a
thermoregulated Lucite chamber mounted on an Leitz
Fluovert inverted microscope. The cTAL was cannulated
and perfused with this same basic Ringer’s solution, except
that [NaCl] was lowered to 25 mM using N-methyl-D-
glucamine cyclamate (Sigma Chemical Co., St. Louis, MO,
USA) to maintain osmolality at 300 mOsm/kg. The prepa-
ration was bathed in the Ringer’s solution containing 150
mM NaCl, continuously aerated with 100% O2, and ex-
changed at a rate of 1 ml/min. Temperature was maintained
at 37°C. For the experiments, bath or perfusate Ringer’s
solution were modified by isosmotically replacing Na with
N-methyl-D-glucamine and/or Cl with cyclamate in order
to achieve a [Na] and/or [Cl] of zero and 25 mM. All
solutions were adjusted to a pH of 7.4. In some experi-
ments, 100 mM 5-(N-ethyl-N-isopropyl)-amiloride (EIPA),
various concentrations of Ang II (both from Sigma Chem-
ical Co.) and Candesartan (CV-11974; Astra Ha¨ssle, Swe-
den) were added to the bath or perfusate. Data were
collected after an incubation of two to three minutes with
these agents.
pHi measurements
Intracellular pH of macula densa cells was measured
with dual excitation wavelength fluorescence microscopy
(Photon Technologies, Inc., Princeton, NJ, USA) using the
fluorescent probe 29,79-bis-(2-carboxyethyl)-5-(and -6) car-
boxyfluorescein (BCECF; Teflabs, Austin, TX). BCECF
fluorescence was measured at an emission wavelength of
530 nm in response to excitation wavelengths of 500 and
440 nm, alternated at a rate of 25 Hz by a computer
controlled chopper assembly. An adjustable photometer
sampling window was positioned over the macula densa
cells and emitted photons were detected by a Leitz pho-
tometer that was modified for photon counting. Magnifica-
tion was 3400 using an Olympus 403 UVFL lens.
Autofluorescence-corrected fluorescence ratio values (500
nm/440 nm) were calculated at a rate of 5 points/second
using PTI software. Macula densa cells were loaded with
the dye by adding BCECF-AM (10 mM), dissolved in
dimethyl sulfoxide, to the luminal perfusate. Loading re-
quired ;five minutes, at which time cps for both wave-
lengths stabilized at values of at least one order of magni-
tude greater than background fluorescence. BCECF
fluorescence was calibrated using the nigericin/high K
method [29] and fluorescence ratios were converted to pH
units as described previously [26].
[NaCl]L induced alkalinization
The first series of experiments measured pHi during
increases in luminal [NaCl] ([NaCl]L) from 25 to 150 mM in
the presence or absence of luminal or basolateral 1029 M
Ang II, while maintaining bath [NaCl] ([NaCl]B) at 150 mM.
In these studies, a stable control BCECF ratio was main-
tained for at least 100 seconds before an experimental
manipulation was performed. After switching to different
[NaCl]L or solutions containing Ang II, the BCECF ratio
was monitored for an additional 100 to 150 seconds or until
a steady state value was obtained. The perfusate was then
returned to the initial 25 mM Ringer’s solution and a
recontrol value was obtained. Measurements consisted of
the baseline pHi, the magnitude of change in pHi (DpHi),
and the initial rate of alkalinization (DpHi/Dt, calculated
from a linear fit, PTI software) in response to an increase in
[NaCl]L, in the presence or absence of Ang II or EIPA.
Recovery of pHi from an acid load
In further studies macula densa cells were acidified by
removing both [Na]L and [Na]B under Cl free conditions.
Apical Na:H exchanger activity was assessed by the rate of
pHi recovery (DpHi/Dt) from acid load after Na was
returned to only the lumen in the presence or absence of
luminal or basolateral low (1029 M) and high (1026 M)
concentrations of Ang II.
The viability of the cTAL-glomerulus preparation, and
function of the macula densa apical Na:H exchanger was
well preserved for the duration of these studies. In both the
[Na]L-induced alkalinization series and pHi-recovery ex-
periments we performed the same control maneuvers (as
shown in Figs. 1 and 4) five times consecutively over '15
minutes. Baseline pHi was stable and the initial rates of pHi
changes (dpHi/dt) did not vary within this time interval. All
paired experiments in this study did not require more than
10 minutes. Thus time control experiments demonstrated
that the responses over time are reproducible and validate
that the changes seen with Ang II are due to the effects of
this hormone on the Na:H exchanger.
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Statistical analysis
Data are expressed as mean 6 SE. Statistical significance
was tested using Student’s t-test for paired sample. Signif-
icance was accepted at P , 0.05.
RESULTS
[NaCl]L induced alkalinization
In the presence of 25 mM [NaCl]L and 150 mM [NaCl]B,
control macula densa pHi for all experiments averaged
7.22 6 0.02 (N 5 24). As we have described previously [26],
and show in the tracing (Fig. 1), increasing [NaCl]L from 25
to 150 mM resulted in a rapid alkalinization of macula
densa cells, which was sustained and reversible upon the
return of [NaCl]L to 25 mM.
Effect of EIPA (100 mM). As expected from our previous
work [26] using the less potent drug amiloride, Na-depen-
dent alkalinization of macula densa cells was inhibitable by
EIPA, a more effective blocker of Na:H exchange. Thus, in
control experiments, 95 6 2% of the alkalinization occur-
ring with increased [NaCl]L was inhibited by 100 mM
luminal EIPA (N 5 5, P , 0.01). These data reaffirm that
[NaCl]L induced alkalinization is due to an apical Na:H
exchanger.
Effect of Ang II (1029 M). This series of paired experi-
ments were performed to determine the effect of luminal or
basolateral Ang II (1029 M) on macula densa pHi with
increased [NaCl]L from 25 to 150 mM. The effects of Ang II
on baseline pHi and on the rate and magnitude of [NaCl]L
induced alkalinization are depicted in Figure 1, and sum-
marized in Figure 2. Both the basolateral and luminal
administration of Ang II in the presence of 25 mM [NaCl]L,
significantly increased pHi of macula densa cells (DpHi 5
0.17 6 0.03 and 0.19 6 0.04, respectively). In addition,
basolateral or luminal Ang II significantly increased the
magnitude of change in pHi (DpHi) as well as the rate of
alkalinization (DpHi/Dt) in response to an increased
[NaCl]L. The average stimulation of [NaCl]L induced
alkalinization was 69% for luminal and 81% for basolateral
addition of Ang II.
Effect of Candesartan (1028 M). Candesartan was used to
determine if Ang II stimulates macula densa intracellular
alkalinization to increased [NaCl]L via AT1-receptors. As
shown in Figure 3, basolateral or luminal Candesartan
treatment alone had no effect on macula densa baseline
pHi, DpHi or DpHi/Dt with increased [NaCl]L. However,
basolateral or luminal co-administration of Candesartan
with Ang II not only inhibited all of the stimulatory effects
of Ang II, but significantly inhibited the rate of alkaliniza-
tion by 37% (basolateral co-administration) and 43% (lu-
minal co-administration).
Recovery of pHi from an acid load
Another means of assessing Na:H exchange activity is to
evaluate Na-dependent pHi recovery after cellular acidifi-
cation. Under Cl free conditions, and in the presence of 25
mM [Na]L and 0 mM [Na]B, control macula densa pHi for all
experiments averaged 7.35 6 0.05 (N 5 26). Macula densa
cells were acidified (Fig. 4) by removing luminal Na, and
after achieving a steady-state low level of pHi, re-addition
of Na to only the lumen caused a rapid increase in pHi.
Effect of EIPA (100 mM). Consistent with the results
obtained in the previous experimental model, 100 mM
luminal EIPA almost completely (99 6 1%, N 5 5, P ,
0.01) blocked Na-dependent pHi recovery in response to
luminal re-addition of Na. This indicates that the pHi
recovery upon re-addition of luminal Na was strictly due to
apical Na:H exchange.
Effects of low (1029 M) and high (1026 M) dose Ang II. The
effects of basolateral or luminal administration of Ang II
were examined, and the results are summarized in Table 1.
Basolateral or luminal low-dose Ang II significantly in-
creased the initial rate of pHi recovery (by 76% and 71%,
respectively). However, high-dose Ang II significantly in-
hibited pHi recovery (by 45% and 43%, respectively).
Furthermore, high-dose Ang II significantly reduced base-
line pHi when added to either the lumen or the bath (DpHi
5 20.16 6 0.06 and 20.14 6 0.04, respectively).
Fig. 1. Effect of 1029 M basolateral Ang II on
macula densa pHi and alkalinization to
increased [NaCl]L. Addition of Ang II alone,
without changing [NaCl]L, caused an elevation
in macula densa pHi. Furthermore, Ang II
increased the magnitude of change in pHi and
the initial rate of alkalinization to increased
[NaCl]L.
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Effect of Candesartan. Since the actions of Ang II were
equivalent when added to either the lumen or bath, we only
examined the effects of basolateral administration of Can-
desartan in this series of experiments. Candesartan treat-
ment alone had no effect on pHi (7.35 6 0.04 vs. control
7.35 6 0.11, NS) and on the rate of Na-dependent pHi
recovery (DpHi/Dt 5 340 6 38 vs. control 382 6 62 3 10
24
second21, NS). As also shown in Table 1, the stimulatory
effect of low-dose Ang II was not only prevented by 1028 M
Candesartan co-administration, but resulted in a significant
inhibition of pHi recovery by 16%, compared to control. In
contrast, Candesartan co-administration (1025 M) did not
prevent the inhibitory effect of high-dose Ang II, and in
fact caused a more significant inhibition of pHi recovery by
49%, compared to control. Finally, Candesartan co-admin-
istration with high-dose Ang II potentiated the acidification
of macula densa cells (DpHi 5 20.27 6 0.08, P , 0.05) in
the presence of 25 mM [Na]L and zero mM [Na]B.
DISCUSSION
In the present studies, we investigated the effects of Ang
II on macula densa Na:H exchange. This focus was a logical
continuation of our previous work [26] that demonstrated
apical Na:H exchange, and recent findings of Harrison-
Bernard et al [10] of AT1-receptors in macula densa cells.
Furthermore, the fact that Ang II, a specific modulator of
TGF, has been shown to alter transepithelial salt and water
transport [13–15], and directly enhance Na:H exchange in
multiple tubular segments [11–20] suggested the possibility
Fig. 2. Effect of 1029 M basolateral or luminal Ang II on (A) macula
densa pHi, (B) the magnitude of change in pHi, and (C) the initial rate of
alkalinization to increased [NaCl]L. Values are means 6 SE; N 5 7 paired
experiments each, *P , 0.05. Symbols are: (M) control; (f) Ang II.
Fig. 3. Effect of basolateral or luminal 1028 M Candesartan and Cande-
sartan 1 1029 M Ang II on macula densa pHi, the magnitude of change in
pHi and the initial rate of alkalinization to increased [NaCl]L. Values are
means 6 SE; N 5 6 paired experiments each, *P , 0.05. Symbols are: (M)
control; (f) Candesartan; (o) Candesartan 1 Ang II.
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of a direct action of Ang II on macula densa cells. Indeed,
this work is the first evidence that an established modulator
of TGF has a direct effect on macula densa cell function.
[NaCl]L induced alkalinization
Since [NaCl]L at the macula densa is thought to be in the
range of 20 to 60 mM, the initial [NaCl] of the luminal
perfusate was set at 25 mM in order to reflect physiological
conditions. Control pHi averaged 7.22 6 0.02, a value
within the range that has been reported in previous studies
[23–26] at this level of [NaCl]L.
In response to the addition of Ang II to either the bath
or lumen, there was an increase in pHi suggesting that Ang
II was capable of increasing Na:H exchange activity under
the condition of low [NaCl]L. These results are in agree-
ment with previous work [26] demonstrating that in the
presence of 25 mM [NaCl]L, addition of 1 mM amiloride
produced intracellular acidification. This indicates that
Na:H exchange is not at equilibrium at this low [NaCl]L and
that cytosolic [Na] is most likely below 25 mM [25]. In
addition, the effects of Ang II on cell pHi might involve
other transport mechanisms that could effect pHi directly
or indirectly through changes in [Na]i. Such systems as the
apical Na:2Cl:K cotransporter [22–25], basolateral Na:H
exchanger [30], and Na:HCO3 cotransporter could directly
or indirectly influence macula densa pHi. It should be
noted that these experiments were performed in nominally
bicarbonate free solutions and so the contribution of a
Na:HCO3 cotransporter to the Ang II-induced changes in
macula densa pHi is less likely. The important point,
however, is that under steady-state conditions where lumen
and bath [NaCl] did not vary, Ang II produced significant
alkalinization of these cells.
In response to an increase in [NaCl]L there was an
alkalinization of macula densa cells. Increases in [NaCl]L
from 25 to 150 mM resulted in a 0.54 6 0.04 unit increase
in pHi, and this magnitude of increase in pHi is in agree-
ment with our previous work [26]. Also, we found that
NaCl-dependent alkalinization of macula densa cells was
nearly completely (95%) inhibited by EIPA, a blocker of
Na:H exchanger. In previous work the macula densa apical
Na:H exchanger was poorly inhibited by amiloride (1 mM Å
Fig. 4. Effect of 1029 M basolateral Ang II on the rate of recovery from an acid load imposed by bilateral Na removal. Removal of Na from both the
lumen and bath caused a rapid decrease in pHi, whereas readdition of Na to only the lumen caused a rapid increase. Addition of Ang II greatly increased
the rate of pHi recovery from the acid load.
Table 1. Effect of angiotensin II (Ang II) w/without Ang II subtype I receptor (AT1-receptor) blockade on baseline pHi and the initial rate of Na-








% of controlControl Ang II Control Ang II
Low Ang II (1029 M)
Basolateral 5 7.35 6 0.11 7.34 6 0.10 20.01 6 0.03 323 6 91 527 6 38 176%*
Luminal 5 7.31 6 0.06 7.27 6 0.07 20.03 6 0.01 348 6 73 519 6 67 171%*
High Ang II (1026 M)
Basolateral 6 7.35 6 0.07 7.18 6 0.10 20.16 6 0.06* 404 6 53 222 6 21 55%*
Luminal 5 7.37 6 0.04 7.23 6 0.08 20.14 6 0.04* 427 6 30 231 6 28 57%*
Candesartan (1028 or 1025 M)
Low Ang II 5 7.35 6 0.04 7.29 6 0.06 20.07 6 0.01 340 6 37 274 6 19 84%*
High Ang II 5 7.35 6 0.04 6.93 6 0.09 20.27 6 0.08* 340 6 37 147 6 23 51%*
Values are mean 6 SE; N 5 number of paired experiments. Macula densa cells were acidified by removing Na from both luminal and basolateral
solutions. At a steady-state low level of pHi, Na was returned to only the lumen. Initial rates of pHi recovery (DpHi/Dt) were determined by linear fit
using PTI software. The Ang II DpHi/Dt (% of control) represents the stimulation/inhibition of Na re-addition induced pHi recovery produced by Ang
II.
Peti-Peterdi and Bell: Ang II and macula densa Na:H exchange 2025
36% inhibition) [26]. EIPA, however, is a much more
effective inhibitor of the “amiloride-resistant” isoforms of
the exchanger and the present findings concur with similar
work in other cell systems [11, 15].
In our studies, the magnitude and rate of increase in
macula densa pHi in response to increased [NaCl]L was
significantly enhanced by Ang II. Activation of TGF in-
volves an initial increase in [NaCl]L; Ang II would then
appear to augment both the magnitude of Na transport as
well as the alkalinization response of these cells to a given
increase in [NaCl]L. Either or both of these effects, that is,
Na transport or intracellular alkalinization, could be in-
volved in the Ang II-induced increase in TGF sensitivity.
However, it should be noted that this model for examining
the effects of Ang II on apical Na:H exchange does not
exclude the direct or indirect participation of other ionic
transport pathways in Ang II induced changes in pHi. In
order to better understand the effects of Ang II on the
macula densa apical Na:H exchanger, additional experi-
ments were performed to remove or attenuate the potential
contributions of these other pathways to the effects of Ang
II on macula densa pHi.
Recovery of pHi from an acid load
Similar to other work [11, 21, 31], removal of lumen and
bath Na acidified macula densa cells, while re-addition of
Na to only the lumen caused a rapid recovery of pHi. In
these experiments, both luminal and bath solutions were Cl
free in order to inhibit Cl-dependent transport processes
including the Na:2Cl:K cotransporter. Also, bath [Na] was
maintained at zero throughout the experiment to prevent
the possible effect of basolateral Na:H exchange on macula
densa alkalinization. In contrast to our previous results,
Ang II did not produce a significant change in baseline pHi
and DpHi to alterations in [Na]L. There are several poten-
tial explanations for this finding. First, the initial baseline
pHi was higher (more alkaline) in this latter series of
experiments and it is well known that Na:H exchange
activity is reduced at higher pHi [32]. Alternatively, in the
first series of experiments, other transport mechanisms in
addition to the apical Na:H exchanger may be involved in
Ang II induced increases in baseline pHi and DpHi. Indeed,
Geibel, Giebisch and Boron found in isolated proximal
tubule that luminal EIPA failed to significantly reduce Ang
II-mediated alkalinization [11].
In our pHi recovery experiments, we also measured the
initial rate of [Na]L-dependent pHi recovery, which is a
more direct reflection of apical Na:H exchanger activity.
These studies clearly demonstrate that Ang II markedly
stimulates apical Na:H exchange. Thus, although other
ionic transport pathways may be affected by Ang II, it is
clear that there is a direct effect of this hormone on the
activity of apical Na:H exchanger in macula densa cells. Not
too surprising, we also found that the effects of Ang II on
Na:H exchanger activity were dose dependent. At 1029 M
Ang II, Na:H exchange activity was increased by more than
70% when administered to either the lumen or bath. In
contrast, Ang II at a concentration of 1026 M inhibited
exchanger activity by almost 50%. In addition, high-dose
Ang II significantly acidified macula densa cells, and this
effect is reminiscent of the partial apical Na:H exchanger
blockade with amiloride from previous studies [26]. This
concentration dependence is similar to that observed for
regulation of Na:H exchanger by Ang II in the proximal
tubule [13–15]. It should be noted that, at the present time,
the physiological relevance of this inhibitory effect of
high-dose Ang II is unclear. Interestingly, co-administra-
tion of Candesartan with high-dose Ang II did not prevent
its inhibitory effects, in fact, Candesartan 1 Ang II further
attenuated exchanger activity. This finding might reflect the
involvement of other Ang II receptor subtypes in this
response, and suggests that AT1-receptor blockade with
Candesartan may unmask the effects of Ang II on other
Ang II receptors. This is also the most likely explanation for
the inhibitory effects of Candesartan 1 low-dose Ang II
co-administration on rates of alkalinization to increased
[NaCl]L and pHi recovery from acid load.
The results of both experimental models demonstrate
that a low concentration of Ang II (1029 M) significantly
stimulates apical Na:H exchanger activity in macula densa
cells. The stimulatory effects of Ang II were equivalent
when added to either the lumen or bath solution, confirm-
ing that this hormone is effective at both the apical and
basolateral membranes. This finding is in accordance with
the identification of receptors for Ang II in multiple
segments of the nephron [10, 33], on both basolateral and
brush-border membranes [10, 34], and with the recent
immunohistochemical demonstration of AT1-receptors in
macula densa cells [10]. The results of the present study
also demonstrate that the stimulatory effects of Ang II
from either the bath or lumen were prevented by co-
administration of Candesartan, an AT1-receptor antago-
nist. Thus, it appears likely that in macula densa cells the
stimulatory effects of Ang II occur via the AT1-receptors
located at both the luminal and basolateral membranes.
The present studies do not address the signaling systems
employed by Ang II in directly stimulating the apical Na:H
exchanger in macula densa cells. Recent studies suggest
that Ang II receptors in renal epithelia are simultaneously
coupled to a number of signal transduction pathways
including adenylate cyclase, protein kinases A and C,
phospholipase C and A2 [13, 14, 35–37]. In the proximal
convoluted tubule, the predominant pathway accounting
for the stimulatory effect of Ang II on the apical Na:H
exchanger is a Gi protein-mediated inhibition of adenylate
cyclase, although secondary pathways are also suggested
involving activation of phospholipase C and A2. Interest-
ingly, older micropuncture studies have demonstrated that
microperfusion with forskolin or phosphodiesterase inhib-
itors, maneuvers that elevate cAMP, also inhibit TGF
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responses [38, 39]. The inhibitory actions of a high concen-
tration of Ang II on Na:H exchange is thought to be
mediated via increased cytosolic Ca21 originating from
both intracellular stores (PLC-IP3) and by Ca
21 entry
(PLA2-P450-arachidonic acid metabolite 5,6-EET) [13, 14,
35–37]. Extensive studies will be required to characterize
the signaling pathways mediating stimulatory and inhibitory
effects of Ang II on macula densa Na:H exchange.
Finally, previous studies have shown that Ang II is a
specific modulator of TGF responses [5–9]. This effect of
Ang II is not necessarily due to the function of Ang II as a
vasoconstrictor. As shown in previous micropuncture stud-
ies, Ang II, but not norepinephrine, enhances TGF re-
sponses in spite of equivalent vasoconstrictive doses [40].
Clearly, AT1-receptors are located at the afferent arteriole
and may be responsible, at least in part, for enhanced TGF
sensitivity. The fact that Ang II can directly effect macula
densa cell function by regulating Na:H exchange activity
would suggest another pathway for the effects of Ang II on
TGF signal modulation.
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APPENDIX
Abbreviations used in this article are: Ang II, angiotensin II; AT1-
receptors, Ang II subtype I receptors; BCECF, 29,79-bis-(2-carboxyethyl)-
5-(and -6) carboxyfluorescein; cTAL, cortical thick ascending limb; EIPA,
5-(N-ethyl-N-isopropyl)-amiloride; [NaCl]B, bath [NaCl]; [NaCl]L, lumi-
nal [NaCl]; pHi, intracellular pH; DpHi, change in intracellular pH;
DpHi/Dt, rate of intracellular pH recovery; TGF, tubuloglomerular feed-
back.
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